Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Open-market sale Blanks Robert sold 5,188 shares at $0.67 ($3,476)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 182,481 shares (grant or award)
  4. 4 Grant or award Director acquired 118,613 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Director acquired 132,299 shares (grant or award)
  7. 4 Grant or award Director acquired 91,240 shares (grant or award)
  8. 4 Grant or award Director acquired 95,802 shares (grant or award)
  9. 4 Grant or award Director acquired 91,240 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Financial Officer sold 73,312 shares at an average $0.65 ($47,696)
  12. 4 Open-market sale Chief Commercial Officer sold 43,920 shares at an average $0.65 ($28,574)
  13. 4 Open-market sale Blanks Robert sold 73,312 shares at an average $0.65 ($47,696)
  14. 4 Open-market sale GRAMMER ELIZABETH A sold 60,821 shares at an average $0.65 ($39,569)
  15. 4 Open-market sale Chief Development Officer sold 61,640 shares at an average $0.65 ($40,102)
  16. 4 Open-market sale President & CEO sold 103,624 shares at an average $0.65 ($67,416)
  17. 4 Open-market sale Chief Development Officer sold 2,013 shares at $0.67 ($1,352)
  18. 4 Open-market sale Chief Financial Officer sold 1,528 shares at $0.67 ($1,026)
  19. 4 Open-market sale Chief Commercial Officer sold 3,425 shares at $0.67 ($2,300)
  20. 4 Open-market sale Blanks Robert sold 1,489 shares at $0.67 ($1,000)

Page 15 of 35 · 696 filings